Could a blood test for an Alzheimer’s-related protein help predict disease risk years before symptoms begin? Jovana Milanko/Stocksy
Blood-based biomarkers of Alzheimer’s disease can be a more accessible and scalable alternative to other diagnostic methods involving expensive imaging scans or invasive cerebrospinal fluid…